# A Open-label Study to Evaluate the Safety of TRV130 in Patients With Acute Pain

> **NCT02656875** · PHASE3 · COMPLETED · sponsor: **Trevena Inc.** · enrollment: 768 (actual)

## Conditions studied

- Acute Pain

## Interventions

- **DRUG:** TRV130

## Key facts

- **NCT ID:** NCT02656875
- **Lead sponsor:** Trevena Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2017-05
- **Final completion:** 2017-08
- **Target enrollment:** 768 (ACTUAL)
- **Last updated:** 2020-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02656875

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02656875, "A Open-label Study to Evaluate the Safety of TRV130 in Patients With Acute Pain". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02656875. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*